cancer drugs

BioNTech
Pharma

BioNTech pays $205M for FDA voucher to speed up cancer pipeline

The BioNTech deal also stands out as most buyers of priority review vouchers keep their identity confidential for competitive reasons.
Angus Liu Nov 11, 2026 8:20am
cancer treatment patient chemotherapy infusion

Pfizer's flooded India injectables plant faces long recovery

Oct 30, 2026 10:20am
radiopharmaceutical radiopharmaceuticals nuclear medicine radiopharma targeted alpha therapy

Radiopharmaceutical player NorthStar locks up $185M

Sep 30, 2026 9:00am
checkered flag finish line racecar

In landmark for Korean biotech, Elevar wins FDA nod for Lyrfigtu

Sep 24, 2026 11:25am
FDA

New FDA oncology chief sets priorities in first interview

Sep 11, 2026 4:00am
Graphic image of a red thumbs down against a blue background

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am